R. Kent Jr McGaughy

Insider Reports History

Entity
Individual
Location
500 Crescent Court, Suite 250, Dallas, TX
Signature
/s/ Sandeep Laumas, M.D. Attorney-in-Fact for R Kent Jr McGaughy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Kent Jr McGaughy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PROCEPT BioRobotics Corp 10%+ Owner Common Stock 2.82M $181M $64.04 May 3, 2024 By White Tailed Ptarmigan, LP
PROCEPT BioRobotics Corp 10%+ Owner Common Stock 554K $35.5M $64.04 May 3, 2024 By Lagos Trust
PROCEPT BioRobotics Corp 10%+ Owner Common Stock 345K $22.1M $64.04 May 3, 2024 By Mallard Fund, L.P.
Apollo Endosurgery, Inc. Director, 10%+ Owner Class A common stock 3.69M $12M $3.25 Dec 28, 2022 By Roadrunner Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Class A common stock 1.31M $4.26M $3.25 Dec 28, 2022 By Killdeer Fund, LP
PROCEPT BioRobotics Corp 10%+ Owner Common Stock 54K $3.46M $64.04 May 3, 2024 By Kestrel Fund, L.P.
Apollo Endosurgery, Inc. Director, 10%+ Owner Class A common stock 675K $2.19M $3.25 Dec 28, 2022 By Curlew Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Class A common stock 401K $1.3M $3.25 Dec 28, 2022 By Mallard Fund, LP
PROCEPT BioRobotics Corp 10%+ Owner Common Stock 4.52K $290K $64.04 May 3, 2024 Direct
Apollo Endosurgery, Inc. Director, 10%+ Owner Class A common stock 63.7K $207K $3.25 Dec 28, 2022 By Kestrel Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Class A common stock 45.6K $148K $3.25 Dec 28, 2022 By Crested Crane, LP
Instil Bio, Inc. Director Stock Option (Right to Buy) 5K Jun 13, 2024 Direct
Apollo Endosurgery, Inc. Director, 10%+ Owner 6.0% Convertible Debentures due 2026 0 Dec 28, 2022 By Curlew Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner 6.0% Convertible Debentures due 2026 0 Dec 28, 2022 By Killdeer Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner 6.0% Convertible Debentures due 2026 0 Dec 28, 2022 By Roadrunner Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Common Stock 0 $6.46 Apr 4, 2023 By Crested Crane, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Common Stock 0 $6.46 Apr 4, 2023 By Curlew Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Common Stock 0 $6.46 Apr 4, 2023 By Kestrel Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Common Stock 0 $6.46 Apr 4, 2023 By Killdeer Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Common Stock 0 $6.46 Apr 4, 2023 By Mallard Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Common Stock 0 $6.46 Apr 4, 2023 By Roadrunner Fund, LP
Apollo Endosurgery, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 $8.69 Apr 4, 2023 Direct
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class A common stock 0 $172.03 Sep 26, 2023 By Lagos Trust
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class A common stock 0 $172.03 Sep 26, 2023 By Traweek Children's Trust
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class A common stock 0 $172.03 Sep 26, 2023 Indirect
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class B common stock 0 $172.03 Sep 26, 2023 By Lagos Trust
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class B common stock 0 $172.03 Sep 26, 2023 By Traweek Children's Trust
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class B common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director, 10%+ Owner Class B common stock 0 $172.03 Sep 26, 2023 Indirect
REATA PHARMACEUTICALS INC Director, 10%+ Owner Stock Option (right to buy) 0 $73.68 Sep 26, 2023 Direct

Insider Reports Filed by R. Kent Jr McGaughy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TIL Instil Bio, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
PRCT PROCEPT BioRobotics Corp May 3, 2024 1 $0 4 May 7, 2024 10%+ Owner
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 25 $0 4 Sep 26, 2023 Director, 10%+ Owner
TIL Instil Bio, Inc. Jun 14, 2023 1 $0 4 Jan 10, 2024 Director
RETA REATA PHARMACEUTICALS INC Jun 7, 2023 2 $120K 4 Jun 9, 2023 Director, 10%+ Owner
APEN Apollo Endosurgery, Inc. Apr 4, 2023 7 $0 4 Apr 4, 2023 Director, 10%+ Owner
RETA REATA PHARMACEUTICALS INC Mar 3, 2023 1 $0 4 Mar 7, 2023 Director, 10%+ Owner
APEN Apollo Endosurgery, Inc. Dec 28, 2022 6 $3.75 4 Dec 30, 2022 Director, 10%+ Owner
PRCT PROCEPT BioRobotics Corp Dec 5, 2022 1 $0 4 Dec 7, 2022 10%+ Owner
PRCT PROCEPT BioRobotics Corp Nov 14, 2022 1 $0 4 Nov 16, 2022 10%+ Owner
PRCT PROCEPT BioRobotics Corp Sep 9, 2022 1 $0 4 Sep 13, 2022 10%+ Owner
PRCT PROCEPT BioRobotics Corp Sep 6, 2022 1 $0 4 Sep 8, 2022 10%+ Owner
APEN Apollo Endosurgery, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
RETA REATA PHARMACEUTICALS INC Jun 8, 2022 2 $115K 4 Jun 10, 2022 Director, 10%+ Owner
TIL Instil Bio, Inc. May 20, 2022 1 $0 4 May 25, 2022 Director
TIL Instil Bio, Inc. Mar 15, 2022 1 $0 4 Mar 17, 2022 Director
RETA REATA PHARMACEUTICALS INC Jan 3, 2022 1 $6.44K 4 Jan 5, 2022 Director, 10%+ Owner
APEN Apollo Endosurgery, Inc. Oct 15, 2021 3 $5.3M 4 Oct 19, 2021 Director, 10%+ Owner
RETA REATA PHARMACEUTICALS INC Jun 10, 2021 2 $57.4K 4 Jun 14, 2021 Director, 10%+ Owner